In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers.

LONDON, GREATER LONDON, UNITED KINGDOM, October 8, 2025 /EINPresswire.com/ -- What Is The Expected Cagr For The Circulating Tumor DNA (CtDNA) Methylation Market Through 2025? The market size for ...

AI is revolutionizing the IVD market by enhancing diagnostic accuracy and speed. Key opportunities lie in AI integration across workflows, cloud solutions, regulatory support, and supply chain ...

Researchers have created a two-stage acne patch with tiny arrowhead-shaped spikes that deliver healing compounds directly under the skin. Trials showed pimples vanished in seven days, and the ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

Impact of Bone Metastasis in Stage IV Non–Small Cell Lung Cancer Treated With Durvalumab and Tremelimumab With or Without Chemotherapy: A Retrospective Analysis of the CCTG BR.34 Trial Human epidermal ...

Illumina Inc., the California-based genomics major, is sharpening its focus on India with plans to expand its business in the country three to five times over the next five to seven years. The company ...